How to Cite
Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Clinical Oncohematology. 2024;(2):227–228. doi:10.21320/6nkr3a68.
Keywords
Abstract
Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.